Navigation Links
FDA Advisory Committee Recommends Approval of PEGINTRON(R) for the Adjuvant Treatment of Stage III Malignant Melanoma
Date:10/5/2009

a is the deadliest form of skin cancer. The American Cancer Society estimates that in the United States in 2009 there will be 68,720 new cases of malignant melanoma, and approximately 8,650 people will die from this disease.

About The Melanoma Trial

The efficacy and safety of PEGINTRON was assessed in a trial led by the European Organisation for the Research and Treatment of Cancer (EORTC) and implemented in 101 sites across Europe. In this randomized, controlled trial of 1,256 melanoma patients, pegylated interferon alfa-2b (N=627) vs. observational arm (N=629) had a significant and sustained impact on relapse-free survival (RFS). Median RFS was 34.8 months in the pegylated interferon alfa-2b arm vs. 25.5 months in the observational arm (p-value 0.01).

In this trial, patients receiving PEGINTRON experienced mild-to-moderate or severe side effects. The most common side effects of PEGINTRON are: fatigue, elevations in blood liver function tests, depression, flu-like symptoms (including fever and chills, headache, aches and pains, loss of appetite, nausea); a reaction at the site of injection; changes in hematology tests, including neutropenia (low neutrophil count), anemia (low hemoglobin) and thrombocytopenia.

Pegylated interferon alfa-2b is a longer-acting form of interferon alfa-2b made by attaching an inert molecule called polyethylene glycol, or PEG, to the interferon alfa-2b molecule. This modification increases the size of the interferon molecule and results in slower elimination from the body, allowing for less frequent dosing than required for standard interferon.

Pegylated interferon alfa-2b is not approved for treatment of melanoma in the U.S. and is marketed as PEGINTRON® for other indications in the U.S. Full prescribing information in the U.S. may be found at '/>"/>

SOURCE Schering-Plough Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine news :

1. Genaera Announces Formation of Scientific Advisory Board for Obesity Drug Candidate Trodusquemine (MSI-1436)
2. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
3. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
4. Patient Safety Authority Board of Directors Names Infection Advisory Panel
5. Broker a Suite of Research & Advisory Services to Enhance Human Resources
6. Lynn Clark Callister, National Leader in Maternal-Child Health Nursing, Joins March of Dimes Advisory Council
7. MaxLife Fund Corp. appoints Daniel E. Kahan, to its Advisory Board
8. Delta Dental Plans Association Forms National Scientific Advisory Committee
9. Alter+Care Creates the Advisory Board
10. Patient Safety Authority Releases Advisory Focusing on Common Causes of Medication Errors
11. Susan G. Komen for the Cure Appoints Dr. Amelie G. Ramirez to Scientific Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... Researchers have found that environment has a much ... a severe, often painful food allergy that renders ... foods. , Eosinophils are normal cellular components ... too many eosinophils they can cause a variety ... inflammation and resulting tissue damage, often in the ...
(Date:9/22/2014)... surprise, it turned out to be an old acquaintance: ... has hitherto always been considered an anchor protein. The ... , Essential: importing enzymes into peroxisome ... degradation of long-chain fatty acids and cellular toxins. In ... enzymes have to be imported into the peroxisomes first. ...
(Date:9/22/2014)... Cancer Science Institute of Singapore (CSI Singapore) at ... an increase in a gene known as Leo1 ... acute myelogenous leukaemia (AML), increasing the incidence of ... Wee Joo, Deputy Director and Senior Principal Investigator ... University Cancer Institute, Singapore, the scientists discovered that ...
(Date:9/22/2014)... Texas (PRWEB) September 22, 2014 ... and treatment, will work with companies to help employees ... the development of diabetes as part of a collaboration ... Diabetes @ Work initiative. , PreDiabetes Centers Medical ... Department of Transportation in Austin on Tuesday, October 21st ...
(Date:9/22/2014)... 22, 2014 The invitation only ... attended by 60 industry executives and thought leaders ... International, GoodLife, Retro Fitness, and Xsport Fitness. Also ... retention and marketing agencies and private equity investors ... gym members. , The Summit highlighted best practices ...
Breaking Medicine News(10 mins):Health News:Environment plays bigger role than genetics in food allergic disease eosinophilic esophagitis 2Health News:The accelerator of molecular motors 2Health News:Singapore researchers discover a gene that increases incidence of AML 2Health News:PreDiabetes Centers to Offer Diabetes Screening at Several Companies Around Austin 2Health News:PreDiabetes Centers to Offer Diabetes Screening at Several Companies Around Austin 3Health News:Motionsoft Concludes Inaugural 2014 Technology Summit 2Health News:Motionsoft Concludes Inaugural 2014 Technology Summit 3
... chief of Renal Medicine and director of the Nephrology ... of medicine at Boston University School of Medicine (BUSM) ... Castle Connolly Medical Ltd. , The America,s Top Doctors ... a trusted and authoritative resource for identifying top doctors ...
... To improve the quality of the rapidly expanding array ... entered into a Memorandum of Understanding (MOU) with the ... for Biological Standards and Control (NIBSC) of the United ... plants or animals, rather than those created in a ...
... related to quality of marriage relationship, , , THURSDAY, Dec. ... poorer outcomes for women with breast cancer, a new ... in troubled marriages had higher levels of stress, less ... of illness than women who reported good marriages. ...
... men with chronic prostatitis, a painful disorder of the ... symptoms in recently diagnosed men who had not been ... trial sponsored by the National Institute of Diabetes and ... Institutes of Health (NIH). The study is to be ...
... Society has worked out new guidelines for the diagnosis ... Malignant melanoma is responsible for 90% of deaths from ... last 30 years and UV radiation is thought to ... , Claus Garbe of Tbingen University and his ...
... time with kids is one option to consider , , THURSDAY, ... be important considerations when you,re looking for children,s Christmas gifts, ... Philadelphia. , "Parents often feel like they have to ... chairman and professor of occupational therapy, said in a university ...
Cached Medicine News:Health News:Marital Distress May Affect Breast Cancer Recovery 2Health News:Common treatment for chronic prostatitis fails to reduce symptoms 2Health News:'Hot' Toys May Not Be the Best Present 2
(Date:9/22/2014)... NORTH CHICAGO, Ill. , Sept. 22, 2014 ... that data from several clinical studies evaluating potential ... be presented at the upcoming 2014 European Society ... in Madrid, Spain . Data ... study evaluating the safety and efficacy of veliparib ...
(Date:9/22/2014)... , Sept. 22, 2014 Arena Pharmaceuticals, Inc. (NASDAQ: ... scheduled to present a corporate overview and update at ... September 26, 2014, at 11:30 a.m. Eastern Time (8:30 ... New York City . ... available under the investor relations section of Arena,s website ...
(Date:9/22/2014)... , September 22, 2014 ... "Cell Line Development Market by Product (Equipment, Media and ... Tissue Engineering & Regenerative medicine, Toxicity Testing, Research, ... 2019", published by MarketsandMarkets, analyzes and studies the ... Browse 114 market data tables and ...
Breaking Medicine Technology:AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 2AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 3AbbVie to Present Clinical Study Data on Potential New Oncology Medicines at the 2014 European Society of Medical Oncology Annual Meeting 4Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 2Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference 3Cell Line Development Market Worth $3.96 Billion by 2019 2Cell Line Development Market Worth $3.96 Billion by 2019 3Cell Line Development Market Worth $3.96 Billion by 2019 4
... is a family of solutions that ... individuals inside hospitals, healthcare facilities, or ... The target tracking areas are networked ... of radio frequency identification (RFID) readers ...
Assetrac allows identification, location, and protection of your assets....
... The RoamAlert Integrity system builds ... ECO. All door controllers in the ... computer running a standard Windows® operating ... the use of a personal computer, ...
... uses RFID to gather patient ... departments such as surgical and ... updates of patient location to ... care events have occurred and ...
Medicine Products: